Evidence map›Paper›PMID 42619596›Full record

ArticleStatistics in medicine2026

Using Latent Representations to Link Disjoint Longitudinal Data for Mixed-Effects Regression.

Clemens Schächter, Maren Hackenberg, Michelle Pfaffenlehner, Félix B Tambe-Ndonfack, Thorsten Schmidt, Astrid Pechmann, Janbernd Kirschner, Jan Hasenauer, Harald Binder

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Clemens SchächterInstitute of Medical Biometry and Statistics (IMBI), Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0009-0008-6775-2377
Maren HackenbergInstitute of Medical Biometry and Statistics (IMBI), Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0003-4403-634X
Michelle PfaffenlehnerInstitute of Medical Biometry and Statistics (IMBI), Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0001-9631-5733
Félix B Tambe-NdonfackDepartment of Mathematical Stochastics, Mathematical Institute, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0009-0008-4193-7533
Thorsten SchmidtDepartment of Mathematical Stochastics, Mathematical Institute, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0001-9254-4010
Astrid PechmannDepartment of Neuropediatrics and Muscle Disorders, Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.
Janbernd KirschnerDepartment of Neuropediatrics and Muscle Disorders, Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0003-1618-7386
Jan HasenauerBonn Center for Mathematical Life Sciences, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-4935-3312
Harald BinderInstitute of Medical Biometry and Statistics (IMBI), Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0002-5666-8662

Funding

Deutsche Forschungsgemeinschaft 499552394
6 · The paper itself

Abstract

Many rare diseases offer limited established treatment options, leading patients to switch therapies when new medications emerge. To analyze the impact of such treatment switches within the low sample size limitations of rare disease trials, it is important to use all available data sources. This, however, is complicated when the use of measurement instruments changes during the observation period, for example when instruments are adapted to specific age ranges. The resulting disjoint longitudinal data trajectories complicate the application of traditional modeling approaches like mixed-effects regression. We tackle this by mapping observations of each instrument to an aligned low-dimensional temporal trajectory, enabling longitudinal modeling across instruments. Specifically, we employ a set of variational autoencoder architectures to embed item values into a shared latent space for each time point. Temporal disease dynamics and treatment switch effects are then captured through a mixed-effects regression model applied to latent representations. To enable statistical inference, we present a novel statistical testing approach that accounts for the joint parameter estimation of mixed-effects regression and variational autoencoders. The methodology is applied to quantify the impact of treatment switches for patients with spinal muscular atrophy. Here, our approach aligns motor performance items from different measurement instruments for mixed-effects regression and maps estimated effects back to the observed item level to quantify the treatment switch effect. Our approach allows for model selection as well as for assessing effects of treatment switching. The results highlight the potential of modeling in joint latent representations for addressing small data challenges.

Indexed as

Models, StatisticalAutoencoderHumansLongitudinal StudiesRegression Analysismeasurement instrument alignmentmixed‐effects regressionsmall dataspinal muscular atrophystatistical inferencetreatment switchesvariational autoencoder

Identifiers

PMID42619596
PMCPMC13491306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.